News about "pharmaceutical companies"

Tive Report Warns of Widening Gap Between Pharma Industry Growth and Supply-Chain Readiness

Tive Report Warns of Widening Gap Between Pharma Industry Growth and Supply-Chain Readiness

Future of pharma supply chains: A new report by Tive has highlighted a widening gap between the pharmaceutical industry’s rapid growth and the readiness of its supply chains, a shortfall that could result in higher rates of product spoilage, regulatory penalties, and costly disruptions if left unresolved.

Pharmaceutical Companies | 27/10/2025 | By Dineshwori 148

CCT Launches New Campaign to Elevate Digitalisation in Pharma Logistics

CCT Launches New Campaign to Elevate Digitalisation in Pharma Logistics

Leading temperature-controlled solution provider Cold Chain Technologies (CCT) has launched a new campaign titled “Smart Chain, Clear Gain,” aimed at redefining how pharmaceutical companies approach compliance, efficiency and value in cold chain logistics.

Pharmaceutical Companies | 30/09/2025 | By Dineshwori

Agilent Technologies, Lunit Partner to Develop AI-Powered Companion Diagnostic Tools

Agilent Technologies, Lunit Partner to Develop AI-Powered Companion Diagnostic Tools

Agilent Technologies has entered into a nonexclusive collaboration with Korea-based Lunit to develop AI-based companion diagnostic solutions.

Pharmaceutical Companies | 23/09/2025 | By Dineshwori 112

Aenova Expands Microbiology QC Lab at Latina Site to Boost Sterile Manufacturing

Aenova Expands Microbiology QC Lab at Latina Site to Boost Sterile Manufacturing

Aenova has announced a major expansion of its microbiology quality control (QC) laboratory at its Latina site in Italy to attract new customers seeking expertise in sterile manufacturing.

Pharmaceutical Companies | 13/09/2025 | By Dineshwori 262

Pfizer, Novartis, Roche Lead Net-Zero Pharma Supply Chain Transition

Pfizer, Novartis, Roche Lead Net-Zero Pharma Supply Chain Transition

Europe currently dominates the global net-zero pharma supply chain market supported by strict climate regulations, while Asia-Pacific is the fastest-growing region, spurred by new government-led sustainability policies.

Pharmaceutical Companies | 11/09/2025 | By Dineshwori 230

Pharma Logistics: Sensos Launches GDP-compliant Cellular Smart Label

Pharma Logistics: Sensos Launches GDP-compliant Cellular Smart Label

Sensos’ first fully GDP-compliant cellular smart Label replaces outdated data loggers with a validated solution to ensure compliance.

Pharmaceutical Companies | 01/09/2025 | By Dineshwori 120

CDSCO Mandates Online Submission of CGTP Clinical Trial Applications via SUGAM Portal

CDSCO Mandates Online Submission of CGTP Clinical Trial Applications via SUGAM Portal

For now on, offline submissions of clinical trial applications for Cell and Gene Therapy Products (CGTPs) will not be accepted by the CDSCO.

Pharmaceutical Companies | 11/07/2025 | By Dineshwori 205

Lupin Signs USD 50 million Deal with Zentiva to Commercialise Biosimilar Certolizumab Pegol Globally

Lupin Signs USD 50 million Deal with Zentiva to Commercialise Biosimilar Certolizumab Pegol Globally

Zentiva will be responsible for marketing and distribution of Lupin’s biosimilar Certolizumab Pegol outside the USA and Canada—primarily across Europe and the CIS (Commonwealth of Independent States) region.

Pharmaceutical Companies | 09/07/2025 | By Dineshwori 223

Konstellate Unveils New AI-Powered Platform for Pharma Decision-Makers

Konstellate Unveils New AI-Powered Platform for Pharma Decision-Makers

The AI-powered platform, with the ability to track and summarize KOL discussions, solves one of the biggest pain points that is frequently experienced in healthcare decision-making - fragmented insights from KOLs across articles, podcasts, and videos.

Pharmaceutical Companies | 20/02/2025 | By Aishwarya 224

Lantern Pharma Launches Innovative AI-Powered Module to Advance ADC Development for Cancer

Lantern Pharma Launches Innovative AI-Powered Module to Advance ADC Development for Cancer

The global ADC market is projected to reach USD 30.4 billion by 2028, growing at a CAGR of 41.7 percent, with several recently approved ADCs achieving blockbuster status with annual sales exceeding USD 1 billion.

Pharmaceutical Companies | 28/01/2025 | By Aishwarya 321


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members